Steven Fasman is shedding the general counsel and senior VP titles he’s held since 2014, and taking over as executive VP and chief administrative officer.
July 05, 2022 at 12:39 PM
2 minute read
The original version of this story was published on Corporate Counsel
The top lawyer for global biopharma company Catalent Inc., which has produced more than a billion COVID-19 vaccines and treatments, is shifting to a newly created administrative role as part of an organizational restructuring following the appointment of a new CEO.
Steven Fasman is shedding the general counsel and senior VP titles he’s held since 2014, and taking over as executive VP and chief administrative officer, according to an announcement Tuesday.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Steven Fasman, executive vice president and chief administrative officer with Catalent. Courtesy photo
